Generation of a tamoxifen inducible Tnnt2MerCreMer knock-in mouse model for cardiac studies

Genesis

Volumn 53, Issue 6, 2015, Pages 377-386

  Yan, Jianyun ^a   Sultana, Nishat ^a   Zhang, Lu ^a   Park, David S ^b   Shekhar, Akshay ^b   Hu, Jun ^a   Bu, Lei ^b   Cai, Chen Leng ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiomyocyte; Heart; MerCreMer; Tamoxifen; Tnnt2

Indexed keywords

CRE RECOMBINASE; TAMOXIFEN; TROPONIN T; ACTIN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BETA GALACTOSIDASE; CD31 ANTIGEN; GT(ROSA)26SOR NON-CODING RNA, MOUSE; INTEGRASE; UNTRANSLATED RNA;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE DELETION; HEART FUNCTION; HEART INJURY; HEART MUSCLE CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANIMAL MODEL; CARDIAC MUSCLE; CARDIAC MUSCLE CELL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; EMBRYOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART; IMMUNOHISTOCHEMISTRY; MALE; MAMMALIAN EMBRYO; METABOLISM; PHYSIOLOGY; SMOOTH MUSCLE; TIME FACTOR; TRANSGENIC MOUSE;

MAMMALIA;

ACTINS; ANIMALS; ANTIGENS, CD31; ANTINEOPLASTIC AGENTS, HORMONAL; BETA-GALACTOSIDASE; EMBRYO, MAMMALIAN; FEMALE; GENE EXPRESSION REGULATION; HEART; IMMUNOHISTOCHEMISTRY; INTEGRASES; MALE; MICE, TRANSGENIC; MODELS, ANIMAL; MUSCLE, SMOOTH; MYOCARDIUM; MYOCYTES, CARDIAC; RNA, UNTRANSLATED; TAMOXIFEN; TIME FACTORS; TROPONIN T;

EID: 84931839674     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.22861     Document Type: Article

References (39)

1. Agah R, Frenkel PA, French BA, Michael LH, Overbeek PA, Schneider MD. 1997. Gene recombination in postmitotic cells. Targeted expression of cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J Clin Invest 100:169-179.
2. Ahmad F, Banerjee SK, Lage ML, Huang XN, Smith SH, Saba S, Rager J, Conner DA, Janczewski AM, Tobita K, Tinney JP, Moskowitz IP, Perez-Atayde AR, Keller BB, Mathier MA, Shroff SG, Seidman CE, Seidman JG. 2008. The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy. PLoS One 3:e2642.
3. Bersell K, Choudhury S, Mollova M, Polizzotti BD, Ganapathy B, Walsh S, Wadugu B, Arab S, Kuhn B. 2013. Moderate and high amounts of tamoxifen in alphaMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death. Dis Model Mech 6:1459-1469.
4. Branda CS, Dymecki SM. 2004. Talking about a revolution: the impact of site-specific recombinases on genetic analyses in mice. Dev Cell 6:7-28.
5. Brocard J, Warot X, Wendling O, Messaddeq N, Vonesch JL, Chambon P, Metzger D. 1997. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc Natl Acad Sci USA 94:14559-14563.
6. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, Caron S, Conner DA, Gessler M, Nemer M, Seidman CE, Seidman JG. 2001. A murine model of Holt-oram syndrome defines roles of the T-box transcription factor tbx5 in cardiogenesis and disease. Cell 106:709-721.
7. Buerger A, Rozhitskaya O, Sherwood MC, Dorfman AL, Bisping E, Abel ED, Pu WT, Izumo S, Jay PY. 2006. Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. J Card Fail 12:392-398.
8. Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, Chen J, Evans S. 2003. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 5:877-889.
9. Chen J, Kubalak SW, Chien KR. 1998. Ventricular muscle-restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis. Development 125:1943-1949.
10. Farley FW, Soriano P, Steffen LS, Dymecki SM. 2000. Widespread recombinase expression using FLPeR (flipper) mice. Genesis 28:106-110.
11. Fishman GI, Kaplan ML, Buttrick PM. 1994. Tetracycline-regulated cardiac gene expression in vivo. J Clin Invest 93:1864-1868.
12. Hall ME, Smith G, Hall JE, Stec DE. 2011. Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice. Am J Physiol Heart Circ Physiol 301:H253-H260.
13. Hougen K, Aronsen JM, Stokke MK, Enger U, Nygard S, Andersson KB, Christensen G, Sejersted OM, Sjaastad I. 2010. Cre-loxP DNA recombination is possible with only minimal unspecific transcriptional changes and without cardiomyopathy in tg(alphaMHC-MerCreMer) mice. Am J Physiol Heart Circ Physiol 299:H1671-H1678. 167
14. Huang J, Elicker J, Bowens N, Liu X, Cheng L, Cappola TP, Zhu X, Parmacek MS. 2012. Myocardin regulates bmp10 expression and is required for heart development. J Clin Invest 122:3678-3691.
15. Hungerford JE, Owens GK, Argraves WS, Little CD. 1996. Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Dev Biol 178:375-392.
16. Indra AK, Warot X, Brocard J, Bornert JM, Xiao JH, Chambon P, Metzger D. 1999. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(t2) recombinases. Nucleic Acids Res 27:4324-4327.
17. Jiao K, Kulessa H, Tompkins K, Zhou Y, Batts L, Baldwin HS, Hogan BL. 2003. An essential role of bmp4 in the atrioventricular septation of the mouse heart. Genes Dev 17:2362-2367.
18. Jiao K, Langworthy M, Batts L, Brown CB, Moses HL, Baldwin HS. 2006. Tgfbeta signaling is required for atrioventricular cushion mesenchyme remodeling during in vivo cardiac development. Development 133:4585-4593.
19. Koitabashi N, Bedja D, Zaiman AL, Pinto YM, Zhang M, Gabrielson KL, Takimoto E, Kass DA. 2009. Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models. Circ Res 105:12-15.
20. Koyanagi M, Bushoven P, Iwasaki M, Urbich C, Zeiher AM, Dimmeler S. 2007. Notch signaling contributes to the expression of cardiac markers in human circulating progenitor cells. Circ Res 101:1139-1145.
21. Kuo CT, Morrisey EE, Anandappa R, Sigrist K, Lu MM, Parmacek MS, Soudais C, Leiden JM. 1997. Gata4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev 11:1048-1060.
22. Lexow J, Poggioli T, Sarathchandra P, Santini MP, Rosenthal N. 2013. Cardiac fibrosis in mice expressing an inducible myocardial-specific cre driver. Dis Model Mech 6:1470-1476.
23. Lombardi R, Bell A, Senthil V, Sidhu J, Noseda M, Roberts R, Marian AJ. 2008. Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies. Cardiovasc Res 79:109-117.
24. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L, Harvey RP. 1995. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 9:1654-1666.
25. Mack CP, Owens GK. 1999. Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions. Circ Res 84:852-861.
26. Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, Ng LL, Palmiter RD, Hawrylycz MJ, Jones AR, Lein ES, Zeng H. 2010. A robust and high-throughput cre reporting and characterization system for the whole mouse brain. Nat Neurosci 13:133-140.
27. Molkentin JD, Robbins J. 2009. With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure. J Mol Cell Cardiol 46:130-136.
28. Moses KA, DeMayo F, Braun RM, Reecy JL, Schwartz RJ. 2001. Embryonic expression of an Nkx2-5/cre gene using rosa26 reporter mice. Genesis 31:176-180.
29. Nishii K, Morimoto S, Minakami R, Miyano Y, Hashizume K, Ohta M, Zhan DY, Lu QW, Shibata Y. 2008. Targeted disruption of the cardiac troponin T gene causes sarcomere disassembly and defects in heartbeat within the early mouse embryo. Dev Biol 322:65-73.
30. Robbins J. 2004. Genetic modification of the heart: exploring necessity and sufficiency in the past 10 years. J Mol Cell Cardiol 36:643-652.
31. Sato Y, Kita T, Takatsu Y, Kimura T. 2004. Biochemical markers of myocyte injury in heart failure. Heart 90:1110-1113.
32. Sauer B, Henderson N. 1988. Site-specific DNA recombination in mammalian cells by the cre recombinase of bacteriophage p1. Proc Natl Acad Sci USA 85:5166-5170.
33. Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, Penninger JM, Molkentin JD. 2001. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible cre protein. Circ Res 89:20-25.
34. Song L, Yan W, Chen X, Deng CX, Wang Q, Jiao K. 2007. Myocardial smad4 is essential for cardiogenesis in mouse embryos. Circ Res 101:277-285.
35. Soriano P. 1999. Generalized lacZ expression with the rosa26 cre reporter strain. Nat Genet 21:70-71.
36. Verrou C, Zhang Y, Zurn C, Schamel WW, Reth M. 1999. Comparison of the tamoxifen regulated chimeric cre recombinases MerCreMer and CreMer. Biol Chem 380:1435-1438.
37. Walsh S, Ponten A, Fleischmann BK, Jovinge S. 2010. Cardiomyocyte cell cycle control and growth estimation in vivo-an analysis based on cardiomyocyte nuclei. Cardiovasc Res 86:365-373.
38. Wu B, Zhou B, Wang Y, Cheng HL, Hang CT, Pu WT, Chang CP, Zhou B. 2010. Inducible cardiomyocyte-specific gene disruption directed by the rat tnnt2 promoter in the mouse. Genesis 48:63-72.
39. Zhang Y, Riesterer C, Ayrall AM, Sablitzky F, Littlewood TD, Reth M. 1996. Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res 24:543-548.